Common use of Requirements for Engaging External Experts and Healthcare Professionals Clause in Contracts

Requirements for Engaging External Experts and Healthcare Professionals. Use of External Experts within R&D The Parties believe that the engagement of external experts in R&D should be done in accordance with the following principles: · There must be a legitimate need for the services of the expert that cannot be fulfilled in-house, and the minimum number of experts needed should be used · Selection of experts should be based solely on the expert’s qualifications and expertise in the subject matter for which such expert is retained · The expert’s services must be documented in a written signed agreement · Compensation must be based on fair market value for the services provided · Reimbursement or pre-payment for costs associated with travel, lodging, meals and hospitality (i.e. refreshments, background music at meetings) for an expert are acceptable if permitted by all law for the location in which the services are rendered and are modest in value · Experts shall not receive any gifts of any value, especially where the expert is also a healthcare professional · Gift includes anything of value, regardless of amount, given to show friendship, appreciation, or support, including meals, entertainment or recreational activities (excludes fair market value for services rendered). Confidential treatment has been requested with respect to portions of this agreement as indicated by “[***]” and such confidential portions have been deleted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. · Healthcare Professionals includes, but is not limited to, physicians, their allied health professionals, and medical office staff. This term also applies to pharmacists and employees of pharmacy benefit managers.

Requirements for Engaging External Experts and Healthcare Professionals. Use of External Experts within R&D The Parties believe that the engagement of external experts in R&D should be done in accordance with the following principles: · • There must be a legitimate need for the services of the expert that cannot be fulfilled in-house, and the minimum number of experts needed should be used · • Selection of experts should be based solely on the expert’s qualifications and expertise in the subject matter for which such expert is retained · • The expert’s services must be documented in a written signed agreement · • Compensation must be based on fair market value for the services provided · • Reimbursement or pre-payment for costs associated with travel, lodging, meals and hospitality (i.e. refreshments, background music at meetings) for an expert are acceptable if permitted by all law for the location in which the services are rendered and are modest in value · • Experts shall not receive any gifts of any value, especially where the expert is also a healthcare professional · • Gift includes anything of value, regardless of amount, given to show friendship, appreciation, or support, including meals, entertainment or recreational activities (excludes fair market value for services rendered). Confidential treatment has been requested with respect to portions of this agreement as indicated by “[***]” and such confidential portions have been deleted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. · • Healthcare Professionals includes, but is not limited to, physicians, their allied health professionals, and medical office staff. This term also applies to pharmacists and employees of pharmacy benefit managers.

Requirements for Engaging External Experts and Healthcare Professionals. Use of External Experts within R&D The Parties believe that the engagement of external experts in R&D should be done in accordance with the following principles: · There must be a legitimate need for the services of the expert that cannot be fulfilled in-house, and the minimum number of experts needed should be used · Selection of experts should be based solely on the expert’s qualifications and expertise in the subject matter for which such expert is retained · The expert’s services must be documented in a written signed agreement · Compensation must be based on fair market value for the services provided · Reimbursement or pre-payment for costs associated with travel, lodging, meals and hospitality (i.e. refreshments, background music at meetings) for an expert are acceptable if permitted by all law for the location in which the services are rendered and are modest in value · Experts shall not receive any gifts of any value, especially where the expert is also a healthcare professional · Gift includes anything of value, regardless of amount, given to show friendship, appreciation, or support, including meals, entertainment or recreational activities (excludes fair market value for services rendered). Confidential treatment has been requested with respect to portions of this agreement as indicated by “[***]” and such confidential portions have been deleted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. · Healthcare Professionals includes, but is not limited to, physicians, their allied health professionals, and medical office staff. This term also applies to pharmacists and employees of pharmacy benefit managers.

Requirements for Engaging External Experts and Healthcare Professionals. Use of External Experts within R&D The Parties believe that the engagement of external experts in R&D should be done in accordance with the following principles: · There must be a legitimate need for the services of the expert that cannot be fulfilled in-house, and the minimum number of experts needed should be used · Selection of experts should be based solely on the expert’s qualifications and expertise in the subject matter for which such expert is retained · The expert’s services must be documented in a written signed agreement · Compensation must be based on fair market value for the services provided · Reimbursement or pre-payment for costs associated with travel, lodging, meals and hospitality (i.e. refreshments, background music at meetings) for an expert are acceptable if permitted by all law for the location in which the services are rendered and are modest in value · Experts shall not receive any gifts of any value, especially where the expert is also a healthcare professional Portions of this Exhibit, indicated by the xxxx “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 406 of the Securities Act of 1933, as amended · Gift includes anything of value, regardless of amount, given to show friendship, appreciation, or support, including meals, entertainment or recreational activities (excludes fair market value for services rendered). Confidential treatment has been requested with respect to portions of this agreement as indicated by “[***]” and such confidential portions have been deleted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. · Healthcare Professionals includes, but is not limited to, physicians, their allied health professionals, and medical office staff. staff This term also applies to pharmacists and employees of pharmacy benefit managers.. Portions of this Exhibit, indicated by the xxxx “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 406 of the Securities Act of 1933, as amended EXHIBIT F MATERIAL TRANSFER RECORD [ Aridis Pharmaceuticals LLC (“[Providing or Receiving] Party”) to GlaxoSmithKline Biologicals SA (“[Receiving or Providing] Party”) The Material described below is supplied by the Providing Party to the Receiving Party subject to the terms and conditions of the Collaboration and Option Agreement between Aridis Pharmaceuticals LLC (“Aridis”) and GlaxoSmithKline Biologicals SA (“GSK”) dated as of the day of , 201 (“Agreement”). Duplicate originals of this form shall be executed and one fully-executed form shall be given to the Providing Party and one to the Receiving Party. Description of Material: Quantity of Material provided to the Receiving Party: Purpose of the transfer : In signing below, the Receiving Party acknowledges that it understands and will abide by the terms and conditions under which the Material is provided. Date of Material Sent/Provided to Receiving Party: